Cancer Death Rate Continues to Decline Amid Progress, Challenges, Researchers Report

Tuesday, September 12, 2017

Penn Medicine is mentioned for its involvement, in collaboration with the Children’s Hospital of Philadelphia, in receiving the approval of the world’s first genetically engineered immune therapy for pediatric leukemia.

Article Source: Philadelphia Inquirer